Pushkarev, V. V., Starenki, D. V., Pushkarev, V. M., Kovzun, O. I., & Tronko, M. D. (2015). Inhibitor of the transcription factor NF-кB, DHMEQ, enhances the effect of paclitaxel on cells of anaplastic thyroid carcinoma in vitro and in vivo.
Chicago Style (17th ed.) CitationPushkarev, V. V., D. V. Starenki, V. M. Pushkarev, O. I. Kovzun, and M. D. Tronko. Inhibitor of the Transcription Factor NF-кB, DHMEQ, Enhances the Effect of Paclitaxel on Cells of Anaplastic Thyroid Carcinoma in Vitro and in Vivo. 2015.
MLA (8th ed.) CitationPushkarev, V. V., et al. Inhibitor of the Transcription Factor NF-кB, DHMEQ, Enhances the Effect of Paclitaxel on Cells of Anaplastic Thyroid Carcinoma in Vitro and in Vivo. 2015.
Warning: These citations may not always be 100% accurate.